alvin powers Archives
Study links small pancreas size to faster progression to stage 3 Type 1 diabetes
Feb. 2, 2024—A multicenter, longitudinal study, co-led by investigators at the Vanderbilt Diabetes Research and Training Center, has discovered that a small pancreas size predicts a faster progression to stage 3 Type 1 diabetes (T1D), the point at which clinical diagnosis occurs.
Study links gene network and pancreatic beta cell defects to Type 2 diabetes
Dec. 4, 2023—A comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes.
Powers receives prestigious Veterans Affairs Middleton Award
Nov. 6, 2023—Alvin C. Powers, MD, Joe C. Davis Professor of Biologic Science and professor of Medicine, Molecular Physiology and Biophysics, has received the 2023 William S. Middleton Award, the highest honor awarded by the Department of Veterans Affairs (VA) Biomedical Laboratory Research and Development Service.
Powers announces plan to step down from key diabetes leadership roles
Oct. 17, 2023—Alvin C. Powers, MD, has announced plans to step down effective July 1, 2024, as director of the Vanderbilt Diabetes Center, director of the Vanderbilt Diabetes Research and Training Center, and chief of the Division of Diabetes, Endocrinology and Metabolism.
VUMC receives $28 million to lead national study of COVID-diabetes link
Aug. 2, 2023—Researchers at Vanderbilt University Medical Center have received a four-year, $28 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study the relationship between COVID-19 and diabetes.
Yasminye Pettway selected as the 2023 Vanderbilt Prize Student Scholar
Jul. 6, 2023—Yasminye Pettway has been selected as the 2023 Vanderbilt Prize Student Scholar.
Diabetes Day celebrates 50 years of achievement, spotlights current investigations
May. 23, 2023—anderbilt Diabetes Day, an annual event hosted by the now-named Vanderbilt Diabetes Research and Training Center (DRTC). The event spotlights the work of researchers, and this year also celebrated the 50-year anniversary of the DRTC.
Diabetes research grant receives NIDDK renewal
Sep. 8, 2022—The Vanderbilt Diabetes Research and Training Center is celebrating its 49th year of continual operation with the five-year competitive renewal of a $10.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health.
Vanderbilt Diabetes Day celebrates investigational achievements, looks toward future
May. 23, 2022—Vanderbilt Diabetes Day, an annual event that showcases the work of outstanding scientists and researchers in the fields of diabetes, obesity and metabolism was held this month, and it marked the first time many investigators working under the auspices of the Vanderbilt Diabetes Research and Training Center (DRTC) had gathered in one space since the beginning of the COVID-19 pandemic.
International gathering scrutinizes immune response, beta cell biology in Type 1 diabetes
Nov. 11, 2021— by Jill Clendening Nearly 400 investigators and scientific trainees hailing from 25 different countries recently gathered virtually, across continents and time zones, to share their latest research related to the immunology of Type 1 diabetes during the 18th Immunology of Diabetes Society (IDS) Congress, co-hosted by Vanderbilt University Medical Center and the University of...
Study proves standardized protocol can support reliable MRI use for multisite pancreatic research
Aug. 27, 2021—Researchers with the Vanderbilt Diabetes Research and Training Center (DRTC) at Vanderbilt University Medical Center led a multisite study which has demonstrated that, when controlled and standardized, quantitative magnetic resonance imaging (MRI) of the pancreas is highly reproducible when using different MRI hardware and software at different geographic locations.
Beta cell regeneration
May. 20, 2021—Vanderbilt researchers dissected the complex microenvironment of the pancreatic islet to discover the signals that drive beta cell regeneration — as a possible treatment for diabetes.